PDF icon Download PDF
J Neurol Surg B Skull Base 2020; 81(06): 664-672
DOI: 10.1055/s-0039-1694967
Original Article

Squamous Cell Carcinoma of the Paranasal Sinuses: A Single Center Experience

Marton König 
1   Department of Neurosurgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
,
Terje Osnes
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
3   Department of Otorhinolaryngology, Head and Neck Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
,
Åse Bratland
4   Department of Oncology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
,
Torstein R. Meling
1   Department of Neurosurgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
2   Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
5   Service de Neurochirurgie, Département des Neurosciences Cliniques, Hopitaux Universitaires de Genève, Genève, Switzerland
6   Faculty of Medicine, University of Geneva, Geneva, Switzerland
› Author Affiliations
Funding This research did not receive any specific grant from funding agencies in the public, commercial, or non-for-profit sectors.
› Further Information
Also available atMedOne
   Permissions and Reprints
Preview

Abstract

Objective Squamous cell carcinoma (SCC) of the paranasal sinuses is usually diagnosed at an advanced stage, making curative therapy difficult. The goal of this study was to evaluate the management and outcomes of patients with SCC treated at our institution.

Methods In a population-based consecutive prospective cohort, we conducted an analysis of all patients treated for SCC between 1988 and 2017.

Results A total of 72 patients were included, follow-up was 100%. Mean follow-up was 57 months for the entire cohort, and 108 months for patients with no evidence of disease. Eighty-two percent of all patients had high-stage (T4) disease. Fifty-seven patients underwent treatment with curative intent; consisting of surgery with or without oncologic treatment in 34, and of oncologic treatment only in 23 cases. Fifteen patients received palliative treatment. The rates of overall survival for the entire cohort were 55% at 2, 41% at 5, and 32% at 10 years, and corresponding disease-specific survival (DSS) rates were 55, 45, and 34%, respectively. DSS rates after surgical treatment with curative intent were 81% at 2, 65% at 5, and 54% at 10 years. Retromaxillary involvement and nonradical surgery were negative prognostic factors. Best survival was achieved with the combination of radical surgery and adjuvant oncologic treatment.

Conclusion Surgical resection with a curative intent yielded 65% at 5-year DSS even in this cohort of patients with high-stage SCC and is still considered as the treatment of choice, preferably in combination with adjuvant radiation therapy and chemotherapy.

Keywords

squamous cell carcinoma - survival - outcome - head and neck surgery - neurosurgery


Publication History

Received: 29 April 2019

Accepted: 03 July 2019

Article published online:
05 August 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany